Your innovative solution
AGuIX is a Gadolinium nanoparticle, injectable by IV, that improve MRI-guided radiation therapy, allowing personalized medicine for an optimize radiation treatment. Eliminated by the kidneys without toxicity, AGuIX allow within a single injection tumor delineation and enhancement of treatment efficacy.
Radiation therapy can generates toxicity in the organs surrounding the tumor and CT images are not specific in soft tissue areas. AGuIX enhance the tumor delineation under MRI by enhancing the contrast and boost the effect of the radiation in the tumor. AGuIX can enhance treatment efficacy and might be use to reduce the planned dose to spare the healthy organs.
1/ Radiation Oncology 2/ Contrast Agent 3/ Compagnon diagnosis
1/ Radiosensitizer 2/ MRI agent 3/ Personalized medicine / Various injection mode
Alexandre DetappeEngineer R&D
Nano3D Biosciences, Inc.
Biomedical research is gravitating towards 3D cell culture models and tissue printing. At n3D, we sell kits and services for 3D cell culture. Our core technology is the magnetization of cells, which can then be directed using magnetic forces. In this manner, we can either levitate or bioprint cells. These cultures are faster to assemble than other systems and easier to handle with magnets without losing samples. Check out our products and ourservices for more information on our technology, and how we can help you!
Mr Glauco SouzaPresident and CSO
Nanotech Plus, LLC
Nanotech Plus, LLC is a consulting firm focused on the commercialization of advanced materials. Our clients include Fortune 500 companies to startups as well as government agencies. Whether you need information ranging from a potential market for a new product to an assessment of a patent portfolio, we can help. In our 5 year history, we have had a diverse group of clients with a diverse set of needs- but we've been able to satisfy them all.Specialties
consulting, marketing patent assessment, due diligence
Mr Sam BrauerPrincipal
New York BioLabs
Our mission is to help create the next generation of powerhouse biotech companies by providing entrepreneurs and innovative life-sciences startups with the space and resources they need to test out, challenge, and nurture early ideas. In order to create a fertile environment in which visionaries can thrive, we aim to:
Foster a collaborative atmosphere that allows thought-sharing and creative exchange
Offer best-in-class infrastructure to enable the unfettered practice of science
Promote cost efficiencies through sharing of many services such as permitting, purchasing, maintenance, IT, and security
Anticipate needs and roadblocks for entrepreneurs in order to provide the smoothest possible path to growth
Create a bioinnovation ecosystem that fosters collegial interactions among industry, investors, government, and academia
Dr Nicole McKnightDirector
New York Structural Biology Center
The New York Structural Biology Center, NYSBC, is an organization of 9 eminent academic research institutions. Founded in 1999, NYSBC is a not-for-proﬁt consortium that provides advanced resources in structural biology to its members and outside users. The Center manages two facilities, its main facility in Manhattan and a crystallography facility at the National Synchrotron Light Source (NSLS and NSLS-‐II) at Brookhaven National Laboratories (BNL) on Long Island. NYSBC is a global leader in structural biology with unsurpassed instrumentation and expertise whose services include high throughput gene-to-structure determination, X-ray crystallography, NMR spectroscopy, Cryo-electron microscopy and Protein Production.
New York Structural Biology Center
Founded in 1999 by nine eminent New York academic institutions, the New York Structural Biology Center (NYSBC) is one of the world’s leading centers for structural biology, a field critical for rationally-designed drugs.
Based in Manhattan, we are the only facility in the US that provides all three major technologies used in biomolecule structure determination: X-ray crystallography, NMR spectroscopy and cryo-electron microscopy, as well as high quality protein production.
NYSBC works with academic scientists, biopharmaceutical companies and the US government, on a membership or fee-for-service basis, on projects ranging from protein production to structure determination and drug design.
To find out more, please call us (212-939-0660) or visit our website (www.nysbc.org).
Dr Rui GalvaoSenior Business Development Officer
New York University
More than 175 years ago, Albert Gallatin, the distinguished statesman who served as secretary of the treasury under Presidents Thomas Jefferson and James Madison, declared his intention to establish "in this immense and fast-growing city ... a system of rational and practical education fitting for all and graciously opened to all." Founded in 1831, New York University is now one of the largest private universities in the United States. Of the more than 3,000 colleges and universities in America, New York University is one of only 60 member institutions of the distinguished Association of American Universities
Ms Sadhana ChitaleDirector, Life Sciences/Technology Transfer
New York University School of Medicine
YU School of Medicine is one of the nation’s preeminent academic institutions. For more than 150 years, we have trained thousands of physician-scientists who have helped to shape the course of medical history and enrich the lives of countless people. Through medical education, scientific research, and patient care, we continue to demonstrate our deep, abiding commitment to improving the human condition.
The percentage of NYU graduates who are members of medical school faculties is among the highest in the nation. For most of them, an invaluable part of that training was their service at Bellevue Hospital, one of the nation’s finest municipal hospitals, where NYU physicians have provided clinical and emergency care to
New York City’s poor and immigrant populations for more than a century.
As part of a “biomedical corridor” extending from 23rd to 34th Streets along Manhattan’s East River Drive, our institution is guided by the promise of “translational medicine,” in which scientific discoveries are urgently translated into innovative treatments for patients. To create an environment worthy of rapid medical advances, we are constructing new research and clinical facilities. These state-of-the-art facilities will serve as the home for our physician-scientists who are the intellectual foundation of the School. In addition, we are recruiting a new generation of scholars and teachers who have established national and international reputations. And we are admitting some of the nation’s best and brightest students, many of whom will become tomorrow’s leaders in the medical profession.
Your focus and ours is whether NYU is the right place to pursue your medical education. We hope that this website captures the spirit of the educational enterprise at NYU, as well as the experience of studying medicine in the heart of New York City.
Nadim ShohdyDirector, Drug Discovery Partnerships
NewYorkBIO brings together over 250 of New Yorks bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization. We are the leading advocate for our industry in New York State.
The New York area is the largest and richest bioscience community in the world: among other assets, the region
- boasts over 60% of Big Pharma national or global HQs;
- supports more than 75,000 direct biotechnology jobs and was named Genetic Engineering Newss #1 region in the US to find a biotech job;
- graduates more life science PhDs than any other region in the US;
- is home to over 25% of the clinical trials in the US; and
- lays claim to the worlds largest concentration of academic medical centers.
We drive innovation and support the development and growth of New York States life science industry, our members, and the community by providing a network for information exchange, shared services, and collective action.